Does TACROLIMUS Cause Transplant dysfunction? 944 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 944 reports of Transplant dysfunction have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.0% of all adverse event reports for TACROLIMUS.
944
Reports of Transplant dysfunction with TACROLIMUS
1.0%
of all TACROLIMUS reports
66
Deaths
273
Hospitalizations
How Dangerous Is Transplant dysfunction From TACROLIMUS?
Of the 944 reports, 66 (7.0%) resulted in death, 273 (28.9%) required hospitalization, and 198 (21.0%) were considered life-threatening.
Is Transplant dysfunction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 944 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Transplant dysfunction?
MYCOPHENOLATE MOFETIL (780)
CYCLOSPORINE (610)
SIROLIMUS (468)
ETANERCEPT (449)
DACLIZUMAB (421)
INFLIXIMAB (405)
PREDNISONE (240)
TACROLIMUS\TACROLIMUS ANHYDROUS (198)
THYMOCYTE IMMUNE GLOBULIN NOS (190)
PREDNISOLONE (182)
Which TACROLIMUS Alternatives Have Lower Transplant dysfunction Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB